BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3973 related articles for article (PubMed ID: 1693028)

  • 1. A panel of antibodies useful in the cytologic diagnosis of metastatic melanoma.
    Shoup SA; Johnston WW; Siegler HF; Tello JW; Schlom J; Bigner DD; Bigner SH
    Acta Cytol; 1990; 34(3):385-92. PubMed ID: 1693028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100 immunophenotypes of uveal melanomas.
    Kan-Mitchell J; Rao N; Albert DM; Van Eldik LJ; Taylor CR
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1492-6. PubMed ID: 1696942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
    Johnston WW; Szpak CA; Thor A; Schlom J
    Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant melanoma in fine needle aspirates and effusions. An immunocytochemical study using monoclonal antibodies.
    Angeli S; Koelma IA; Fleuren GJ; Van Steenis GJ
    Acta Cytol; 1988; 32(5):707-12. PubMed ID: 2458662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMB-45 detection in adenocarcinomas.
    Hancock C; Allen BC; Herrera GA
    Arch Pathol Lab Med; 1991 Sep; 115(9):886-90. PubMed ID: 1718237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a panel of antiganglioside monoclonal antibodies to cytologic specimens.
    Vick WW; Tello JW; Wikstrand CJ; He X; Longee D; Fredman P; Svennerholm L; Bigner DD; Johnston WW; Bigner SH
    Acta Cytol; 1992; 36(5):697-705. PubMed ID: 1523927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
    Pluot M; Joundi A; Grosshans E
    Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100 protein immunoreactivity in poorly differentiated carcinomas. Immunohistochemical comparison with malignant melanoma.
    Drier JK; Swanson PE; Cherwitz DL; Wick MR
    Arch Pathol Lab Med; 1987 May; 111(5):447-52. PubMed ID: 2436593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
    Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
    Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KBA.62: a useful marker for primary and metastatic melanomas.
    Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
    Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemistry with monoclonal antibody B72.3 as an adjunct in the cytologic diagnosis of pancreatic carcinoma.
    Ness MJ; Pour PM; Tempero MA; Linder J
    Mod Pathol; 1988 Jul; 1(4):279-83. PubMed ID: 2467286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of a panel of monoclonal antibodies in the evaluation of cytologic specimens from the central nervous system.
    Vick WW; Wikstrand CJ; Bullard DE; Kemshead J; Coakham HB; Schlom J; Johnston WW; Bigner DD; Bigner SH
    Acta Cytol; 1987; 31(6):815-24. PubMed ID: 3425142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of monoclonal antibody HMB-45 in the cytologic diagnosis of melanoma.
    Ordóñez NG; Sneige N; Hickey RC; Brooks TE
    Acta Cytol; 1988; 32(5):684-8. PubMed ID: 3048028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study.
    Argenyi ZB; Cain C; Bromley C; Nguyen AV; Abraham AA; Kerschmann R; LeBoit PE
    Am J Dermatopathol; 1994 Jun; 16(3):233-40. PubMed ID: 7943629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of malignant melanoma with monoclonal antibodies.
    Saxton RE; Burke MW; Torbett B; Fairhurst M; Morton DL; Cochran AJ
    Dis Markers; 1988 Jun; 6(2):97-108. PubMed ID: 3042264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical criteria in the differential diagnosis of malignant melanoma versus carcinoma, lymphoma and sarcoma in fine needle aspirates.
    Domagała W; Chosia M; Bedner E; Weber K; Osborn M
    Patol Pol; 1991; 42(3):73-8. PubMed ID: 1845482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface expression of tumor-associated antigens in primary cultured human colonic epithelial cells from carcinomas, benign tumors, and normal tissues.
    Friedman E; Thor A; Hand PH; Schlom J
    Cancer Res; 1985 Nov; 45(11 Pt 2):5648-55. PubMed ID: 2413994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms.
    McCluggage WG; Bissonnette JP; Young RH
    Int J Gynecol Pathol; 2006 Oct; 25(4):321-9. PubMed ID: 16990706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-100 protein in melanocytic tumors. An immunohistochemical investigation of benign and malignant melanocytic tumors and metastases of malignant melanoma and a characterization of the antigen in comparison to human brain.
    Kindblom LG; Lodding P; Rosengren L; Baudier J; Haglid K
    Acta Pathol Microbiol Immunol Scand A; 1984 Jul; 92(4):219-30. PubMed ID: 6496075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 199.